The researchers examined 40 patients who underwent ACDF for adjacent segment disease. The researchers found:
1. The patients undergoing ACDF for adjacent segment disease reported significant improvement in the NRS-NP, NRS-AP, NDI, SF-12 PCS and ZDS outcomes measures.
2. The patient-reported health states also improved. The patients reported an average two-year gain of 0.54 quality-adjusted life year.
3. The average cost of surgery was $32,616. The average direct costs were $25,391 while the average indirect cost was $7,225.
4. The procedure was associated with average two-year cost per QALY gained of around $69,526.
5. The study authors concluded the procedure was cost effective.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
